Press Releases

VIDA Diagnostics to Address Overcoming Pervasive Challenges in Respiratory Clinical Trials During 12/8 Webinar

Dec 1, 2021, 15:19 PM by
A 12/8 webinar with leading pulmonary disease clinician Dr. Mario Castro will address the rise of imaging in respiratory clinical trials, something worth hearing considering the uncertainty of the long-term impact of COVID-19 and other factors.

What: “The Rise of Imaging in Respiratory Clinical Trials” a webinar hosted by VIDA Diagnostics,
will highlight what is needed to make the clinical trial process more efficient now that the 
pandemic has put a spotlight on lung and respiratory disease. As innovation is rapidly 
underway to treat the long-term effects of COVID-19 - as well as wildfires and smoking/vaping 
that contribute to a long list of devastating pulmonary conditions - clinical trials must improve.

Participants will learn best practices for reducing the 52% failure rate of respiratory drugs in 
clinical trials, and proven strategies to find clinical trial candidates, better prepare sites, and 
streamline the entire process.

Mario Castro, MD, MPH, a leading pulmonary disease clinician, will join Susan Wood, PhD, 
president & CEO VIDA Diagnostics to discuss current challenges in lung and respiratory disease 
clinical trials, novel approaches to securing the right trial participants, and practical strategies 
for running a trial effectively, including expert training with tests and equipment.

When: 10:00 a.m. PST / 12:00 p.m. CST / 1:00 p.m. EST presentation with Q&A

Where: Register for the free webinar by visiting: 
The Rise of Imaging in Respiratory Clinical Trials

Who: Mario Castro, MD, MPH, is the Chief of Pulmonary, Critical Care and Sleep Medicine, Vice-Chair 
for Clinical and Translational Research, and Director of Rainbow Clinical and Translational 
Science Unit, Frontiers at the University of Kansas School of Medicine. He is also on the 
Scientific Advisory Committee of the American Lund Association and an Airways Clinical 
Research Centers principal investigator.

Susan Wood, PhD is president & CEO of VIDA. She has 25+ years of experience championing 
innovative clinical solutions into routine clinical use. Dr. Wood received her Ph.D. from the 
Johns Hopkins Medical Institutions, School of Hygiene and Public Health. Her Ph.D. work 
combined quantifying three-dimensional lung structure with changes in lung function using 
high-resolution CT imaging. 

How: To schedule an interview with Mario Castro and/or Susan Wood, please contact Joanne 
Stanway, jstanway@greenough.biz, 978-273-1473.

For More Information:
Sara Ceder
sceder@vidalung.ai
612-414-4302